• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有血管内皮生长因子的聚乳酸-乙醇酸纳米粒缓释制剂对帕金森病大鼠多巴胺能神经元具有保护作用。

Vascular endothelial growth factor-loaded poly-lactic-co-glycolic acid nanoparticles with controlled release protect the dopaminergic neurons in Parkinson's rats.

作者信息

Meng Xian-Yue, Huang An-Qi, Khan Afsar, Zhang Li, Sun Xiao-Qian, Song Hao, Han Jun, Sun Qian-Ru, Wang Yu-Dan, Li Xue-Li

机构信息

Department of Neurology, Liaocheng People's Hospital and Liaocheng School of Clinical Medicine, Taishan Medical University, Liaocheng, China.

Department of Chemistry, COMSATS University Islamabad, Abbottabad, Pakistan.

出版信息

Chem Biol Drug Des. 2020 Jun;95(6):631-639. doi: 10.1111/cbdd.13681. Epub 2020 Mar 29.

DOI:10.1111/cbdd.13681
PMID:32167672
Abstract

Vascular endothelial growth factor (VEGF) had neuroprotective effects on dopaminergic (DA) neurons. In order to overcome the gastrointestinal digestion and bioaccessibility, VEGF was encapsulated with poly-lactic-co-glycolic acid nanospheres (NS) in order to prevent the VEGF degradation until its release. The caudal administration of VEGF and NS encapsulated VEGF at different doses (1.0, 10.0, and 100.0 ng/ml) on the rats with Parkinson's disease lesion was evaluated. Intravenous injected VEGF at the dose of 1 ng/ml displayed the strongest neuroprotective effect than other groups as well as the stereotaxic group. The NS encapsulated with VEGF can pass through blood-brain barrier and protect the DA neurons. There was no significant difference between intravenous injection method and stereotaxic method, while the first method is simpler and convenient. Injection of NS encapsulated with VEGF may become a valuable neurorescuing therapeutic approach for Parkinson's disease.

摘要

血管内皮生长因子(VEGF)对多巴胺能(DA)神经元具有神经保护作用。为了克服胃肠道消化和生物可及性问题,VEGF被包裹在聚乳酸-乙醇酸纳米球(NS)中,以防止VEGF降解直至其释放。评估了在帕金森病损伤大鼠中以不同剂量(1.0、10.0和100.0 ng/ml)尾静脉注射VEGF和NS包裹的VEGF的情况。静脉注射1 ng/ml剂量的VEGF显示出比其他组以及立体定位组更强的神经保护作用。VEGF包裹的NS能够穿过血脑屏障并保护DA神经元。静脉注射法和立体定位法之间没有显著差异,而第一种方法更简单方便。注射VEGF包裹的NS可能成为一种有价值的帕金森病神经挽救治疗方法。

相似文献

1
Vascular endothelial growth factor-loaded poly-lactic-co-glycolic acid nanoparticles with controlled release protect the dopaminergic neurons in Parkinson's rats.载有血管内皮生长因子的聚乳酸-乙醇酸纳米粒缓释制剂对帕金森病大鼠多巴胺能神经元具有保护作用。
Chem Biol Drug Des. 2020 Jun;95(6):631-639. doi: 10.1111/cbdd.13681. Epub 2020 Mar 29.
2
Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease.在帕金森病部分损伤模型中,联合给予载有血管内皮生长因子(VEGF)和胶质细胞源性神经营养因子(GDNF)的纳米球可提高抗帕金森病疗效。
Int J Nanomedicine. 2014 May 27;9:2677-87. doi: 10.2147/IJN.S61940. eCollection 2014.
3
Neurorescue effects of VEGF on a rat model of Parkinson's disease.血管内皮生长因子对帕金森病大鼠模型的神经保护作用。
Brain Res. 2005 Aug 16;1053(1-2):10-8. doi: 10.1016/j.brainres.2005.05.027.
4
Spatiotemporal release of VEGF from biodegradable polylactic-co-glycolic acid microspheres induces angiogenesis in chick chorionic allantoic membrane assay.可生物降解的聚乳酸-共-羟基乙酸微球中 VEGF 的时空释放诱导鸡胚绒毛尿囊膜血管生成。
Int J Pharm. 2019 Apr 20;561:236-243. doi: 10.1016/j.ijpharm.2019.03.015. Epub 2019 Mar 8.
5
Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization.使用葡聚糖/聚乳酸-乙醇酸共聚物复合微球系统持续递送血管内皮生长因子用于治疗性新生血管形成。
Heart Vessels. 2019 Jan;34(1):167-176. doi: 10.1007/s00380-018-1230-5. Epub 2018 Jul 24.
6
The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model.体外和体内帕金森病模型中,向多巴胺能神经元高剂量和低剂量施用血管内皮生长因子(VEGF)之间的差异。
Brain Res. 2005 Mar 15;1038(1):1-10. doi: 10.1016/j.brainres.2004.12.055.
7
Microfluidic-assisted fabrication of reverse micelle/PLGA hybrid microspheres for sustained vascular endothelial growth factor delivery.微流控辅助制备反胶束/PLGA 杂化微球用于持续血管内皮生长因子传递。
Biotechnol Appl Biochem. 2021 Jun;68(3):616-625. doi: 10.1002/bab.1971. Epub 2020 Jun 26.
8
Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma.多载药 PLGA 微球同时递药用于治疗青光眼的神经保护作用。
J Control Release. 2019 Mar 10;297:26-38. doi: 10.1016/j.jconrel.2019.01.012. Epub 2019 Jan 18.
9
Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.采用复乳/溶剂挥发技术制备载血管内皮生长因子(VEGF)聚(D,L-丙交酯-共-乙交酯)微球及其体外性质考察。
J Microencapsul. 2011;28(1):46-54. doi: 10.3109/02652048.2010.523795.
10
Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.载多巴胺纳米粒经血脑屏障递送至帕金森病大鼠模型中可逆转其功能缺陷。
ACS Nano. 2015 May 26;9(5):4850-71. doi: 10.1021/nn506408v. Epub 2015 Apr 22.

引用本文的文献

1
Nanomedicine: a cost-effective and powerful platform for managing neurodegenerative diseases.纳米医学:一种用于管理神经退行性疾病的经济高效且强大的平台。
Metab Brain Dis. 2025 Mar 11;40(3):142. doi: 10.1007/s11011-025-01564-3.
2
Gene Therapy for Parkinson's Disease Using Midbrain Developmental Genes to Regulate Dopaminergic Neuronal Maintenance.使用中脑发育基因调控多巴胺能神经元维持的帕金森病基因治疗。
Int J Mol Sci. 2024 Nov 18;25(22):12369. doi: 10.3390/ijms252212369.
3
Trends on Novel Targets and Nanotechnology-Based Drug Delivery System in the Treatment of Parkinson's disease: Recent Advancement in Drug Development.
新型靶点及基于纳米技术的药物传递系统治疗帕金森病的研究进展:药物研发的新进展。
Curr Drug Targets. 2024;25(15):987-1011. doi: 10.2174/0113894501312703240826070530.
4
The contribution of β-amyloid, Tau and α-synuclein to blood-brain barrier damage in neurodegenerative disorders.β-淀粉样蛋白、Tau 和 α-突触核蛋白在神经退行性疾病中对血脑屏障损伤的贡献。
Acta Neuropathol. 2024 Feb 12;147(1):39. doi: 10.1007/s00401-024-02696-z.
5
Effect of vascular endothelial growth factor 165 on dopamine level in the retinas of guinea pigs with form-deprivation myopia.血管内皮生长因子 165 对形觉剥夺性近视豚鼠视网膜多巴胺水平的影响。
PeerJ. 2023 Oct 13;11:e16255. doi: 10.7717/peerj.16255. eCollection 2023.
6
The Management of Parkinson's Disease: An Overview of the Current Advancements in Drug Delivery Systems.帕金森病的管理:药物递送系统当前进展概述
Pharmaceutics. 2023 May 15;15(5):1503. doi: 10.3390/pharmaceutics15051503.
7
Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials.基于间充质基质细胞衍生的 secretome 的神经退行性疾病治疗:临床试验概述。
Stem Cell Res Ther. 2023 May 4;14(1):122. doi: 10.1186/s13287-023-03264-0.
8
Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems.用于研究性聚合物微纳系统的抗帕金森病药物
Pharmaceutics. 2022 Dec 20;15(1):13. doi: 10.3390/pharmaceutics15010013.
9
Anti-Parkinsonian Therapy: Strategies for Crossing the Blood-Brain Barrier and Nano-Biological Effects of Nanomaterials.抗帕金森病治疗:跨越血脑屏障的策略及纳米材料的纳米生物学效应
Nanomicro Lett. 2022 Apr 15;14(1):105. doi: 10.1007/s40820-022-00847-z.
10
Growth Factor Therapy for Parkinson's Disease: Alternative Delivery Systems.生长因子治疗帕金森病:替代传递系统。
J Parkinsons Dis. 2021;11(s2):S229-S236. doi: 10.3233/JPD-212662.